DYN
Dyne Therapeutics Inc
16.30$
+1.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.2% | 11.2% | 49.5% | 115.6% | – | – | – | – | – | – | – | – | |
| 19.9% | 72.9% | 56.1% | 171.3% | – | – | – | – | – | – | – | – | |
| 1.3% | 3.3% | 2.3% | 8.7% | – | – | – | – | – | – | – | – | |
| 70.2% | -102.1% | 68.7% | -315.4% | – | – | – | – | – | – | – | – | |
| 0.0% | 32.7% | 23.9% | 44.3% | – | – | – | – | – | – | – | – | |
| -351.2% | -141.8% | -157.2% | -545.3% | – | – | – | – | – | – | – | – | |
| – | 2.7% | 1.6% | 4.3% | – | – | – | – | – | – | – | – | |
| -127.6% | -29.7% | – | – | – | – | – | – | – | – | – | – | |
| 355.4% | -31.5% | 200.7% | -256.7% | – | – | – | – | – | – | – | – | |
| -351.2% | -162.1% | 93.0% | -686.4% | – | – | – | – | – | – | – | – | |
| -4.2% | -21.5% | 25.6% | 71.3% | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.